Frontlight ResearchEarly access
Sjögren's disease trials in Georgia
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peoplePhase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Where
- Tbilisi
- Age
- 18 years to 75 years
- People
- 250 worldwide
- Run by
- Vor Biopharma
See details and how to joinNCT07404865 · EU 2026-525556-28-00